AUSTIN ROBITZER: Open Payments
NPI 1942042445 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $222 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $302 |
| SCPHARMACEUTICALS INC. | 1 | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Amgen Inc. | 2 | $39 |
| Vital Connect, Inc | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FARXIGA, LOKELMA, FUROSCIX, LifeVest, JARDIANCE, Kerendia, ONPATTRO, REPATHA.
Industry payments across KY — which companies pay providers there.
